Perianal Fistulas in Crohn’s Disease Are Predominantly Colonized by Skin Flora: Implications for Antibiotic Treatment?

By West R.   Woude C.   Endtz H.   Hansen B.   Ouwedijk M.   Boelens H.   Kusters J.   Kuipers E.  

Digestive Diseases and Sciences, Vol. 50, Iss. 7, 2005-07 ,pp. : 1260-1263

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of frozen shoulder with subcutaneous TNF-alpha blockade compared with local glucocorticoid injection: a randomised pilot study

By Schydlowsky Pierre  

Clinical Rheumatology, Vol. 31, Iss. 8, 2012-08 ,pp. : 1247-1251

Springer Publishing Company

Access to resources Recommend Favorite

Efalizumab, a Human Monoclonal Anti-CD11a Antibody, in the Treatment of Moderate to Severe Crohn’s Disease: An Open-Label Pilot Study

By James Dustin   Seo Da   Chen Jiajing   Vemulapalli Caroline   Stone Christian  

Digestive Diseases and Sciences, Vol. 56, Iss. 6, 2011-06 ,pp. : 1806-1810

Springer Publishing Company

Access to resources Recommend Favorite

Treatment Algorithms in the Case of Perianal Complications of Crohn’s Disease

By  

Digestive Diseases, Vol. 27, Iss. 4, 2009-11 ,pp. : 565-570

Karger

Access to resources Recommend Favorite

Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism

By Louis E.   Vermeire S.   Rutgeerts P.   De Vos M.   Van Gossum A.   Pescatore P.   Fiasse R.   Pelckmans P.   Reynaert H.   D'Haens G.   Malaise M.   Belaiche J.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 7, 2002-07 ,pp. : 818-824

Informa Healthcare

Access to resources Recommend Favorite